Progress toward hepatitis C virus elimination among people living with HIV–hepatitis C virus coinfection in Canada
Assessing progress toward HCV elimination in the DAA era (2014–2022) within the Canadian Co-infection Cohort
View PublicationAssessing progress toward HCV elimination in the DAA era (2014–2022) within the Canadian Co-infection Cohort
View PublicationCharacterizing sociodemographic and behavioural factors associated with mortality among people living with HIV in British Columbia.
View PublicationExamining the prevalence of self-reported mental health conditions, differences in purpose in life, as measured by the Oregon Brief Purpose Measure, and associated correlates in WLWH and HIV-negative controls
View PublicationA prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV susceptibility
View PublicationExamining disparities in healthcare access, STI testing, and HIV pre-exposure prophylaxis use among immigrant and non-immigrant men who have sex with men.
View PublicationExamining depressive symptoms and health services utilization in people co-infected with HIV-HCV and their association with sustained virologic response during the direct-acting antiviral era
View PublicationExamining characteristics that may indicate an increased probability of unsuccessful DAA HCV treatment.
View PublicationExamining whether the Everyday Discrimination Scale provides valid estimates of racial discrimination that are objectively comparable across racial/ethnic groups or by HIV status.
View PublicationExamining the prevalence of frailty and its correlates among older adults living with HIV in Canada, with a primary interest in nadir CD4 count
View Publication